Pharvaris

1 open jobs

Pharvaris is a Nasdaq-listed late-stage biotech company developing bradykinin B2 receptor antagonists for bradykinin-mediated diseases, with offices in Switzerland, the Netherlands, and the USA. The company focuses on bringing new treatment options to patients with bradykinin-mediated angioedema, a condition characterized by sudden and prolonged swelling attacks that can be life-threatening.